Telitacicept Mechanism of Action—A Chinese Innovative “Dual-Target” Breakout
In the field of autoimmune disease treatment, 2021 marked a significant milestone—the world’s first-in-class dual-target…
News
The IgA Nephropathy New Treatment Revolution: From Supportive Care to Precision Targeting
IgA nephropathy is the most common primary glomerular disease in China, accounting for approximately 40%–50%…
A Breakthrough in Fatal Pulmonary Fibrosis! World’s First PDE4B Inhibitor—Nerandomilast Approved in China
For approximately 5.6 million patients worldwide living with progressive pulmonary fibrosis (PPF), every breath is…
What Causes Plaque Psoriasis? How Does the New Drug Mufemilast Offer a Novel Treatment Choice?
🤔 When well-defined red patches covered in silvery-white scales appear on the skin, it is…
Landmark Approval: Datopotamab Deruxtecan Approval in China, Signaling a Major Shift in Breast Cancer Treatment Landscape
China’s breast cancer treatment landscape has reached a new milestone with the regulatory approval of…
Combating the “Silent Killer”: How Atrasentan is Redefining Primary IgA Nephropathy Treatment and Altering the Course to Kidney Failure
🤔 In China, what is the most common primary glomerulonephritis leading to kidney failure in…
2025 in Review丨Dual Harvest for China Innovative Drugs — How R&D Leadership Met Capital Validation
The year 2025 marked a profound paradigm shift for China’s innovative drug industry. We witnessed…
From Generics to Bio-Engineering: How China is Redesigning the Future of Medicine
For decades, “Made in China” in pharmaceuticals conjured images of generic drugs and manufacturing scale.…
Tibremciclib Capsules Granted Regulatory Approval in China for Advanced Breast Cancer Patients
The National Medical Products Administration (NMPA) of China has officially approved Tibremciclib Capsules (BPI-16350, brand…
New COPD Treatment Launched: What’s New in 2025 and What’s Next for Global and China COPD Care
🫁 Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory condition characterized by persistent airflow…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights